

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitotic metaphase plate congression (GO:0007080) | 4.58225095 |
| 2 | maturation of SSU-rRNA (GO:0030490) | 4.32657370 |
| 3 | purine nucleobase biosynthetic process (GO:0009113) | 4.31973218 |
| 4 | ribosome assembly (GO:0042255) | 4.25553697 |
| 5 | nucleobase biosynthetic process (GO:0046112) | 4.23117744 |
| 6 | ribosome biogenesis (GO:0042254) | 4.19162843 |
| 7 | DNA replication checkpoint (GO:0000076) | 4.18699922 |
| 8 | proteasome assembly (GO:0043248) | 4.17385234 |
| 9 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.14665244 |
| 10 | DNA deamination (GO:0045006) | 4.05491956 |
| 11 | formation of translation preinitiation complex (GO:0001731) | 4.03392682 |
| 12 | DNA replication initiation (GO:0006270) | 4.00925652 |
| 13 | DNA strand elongation (GO:0022616) | 3.92741916 |
| 14 | 7-methylguanosine mRNA capping (GO:0006370) | 3.88210669 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 3.85555845 |
| 16 | spliceosomal snRNP assembly (GO:0000387) | 3.81660212 |
| 17 | RNA capping (GO:0036260) | 3.81120022 |
| 18 | 7-methylguanosine RNA capping (GO:0009452) | 3.81120022 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.78044711 |
| 20 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.73681262 |
| 21 | ribosomal small subunit assembly (GO:0000028) | 3.72028547 |
| 22 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.70097633 |
| 23 | spliceosomal complex assembly (GO:0000245) | 3.69275825 |
| 24 | metaphase plate congression (GO:0051310) | 3.67156932 |
| 25 | regulation of podosome assembly (GO:0071801) | 3.67058051 |
| 26 | protein localization to kinetochore (GO:0034501) | 3.66477229 |
| 27 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.66208483 |
| 28 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.66208483 |
| 29 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.62966176 |
| 30 | DNA unwinding involved in DNA replication (GO:0006268) | 3.61668196 |
| 31 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.56633410 |
| 32 | rRNA modification (GO:0000154) | 3.55338351 |
| 33 | rRNA processing (GO:0006364) | 3.50060149 |
| 34 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.49603178 |
| 35 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.48857509 |
| 36 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.48857509 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.48519073 |
| 38 | chaperone-mediated protein transport (GO:0072321) | 3.48316110 |
| 39 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.46501180 |
| 40 | establishment of chromosome localization (GO:0051303) | 3.44801090 |
| 41 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.44421711 |
| 42 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.44248347 |
| 43 | termination of RNA polymerase III transcription (GO:0006386) | 3.44248347 |
| 44 | termination of RNA polymerase I transcription (GO:0006363) | 3.43062730 |
| 45 | CENP-A containing nucleosome assembly (GO:0034080) | 3.40981458 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.39076673 |
| 47 | rRNA metabolic process (GO:0016072) | 3.38384844 |
| 48 | transcription from RNA polymerase I promoter (GO:0006360) | 3.37586934 |
| 49 | ribosomal large subunit biogenesis (GO:0042273) | 3.36946304 |
| 50 | negative regulation of ligase activity (GO:0051352) | 3.35751741 |
| 51 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.35751741 |
| 52 | IMP biosynthetic process (GO:0006188) | 3.35560950 |
| 53 | mitotic nuclear envelope disassembly (GO:0007077) | 3.33684174 |
| 54 | telomere maintenance via recombination (GO:0000722) | 3.32877518 |
| 55 | chromatin remodeling at centromere (GO:0031055) | 3.30690177 |
| 56 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.27100005 |
| 57 | maturation of 5.8S rRNA (GO:0000460) | 3.25352342 |
| 58 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.23712228 |
| 59 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.23614300 |
| 60 | mitotic recombination (GO:0006312) | 3.23065358 |
| 61 | protein deneddylation (GO:0000338) | 3.20481020 |
| 62 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.19177444 |
| 63 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.18815225 |
| 64 | telomere maintenance via telomere lengthening (GO:0010833) | 3.17166565 |
| 65 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.17113378 |
| 66 | regulation of spindle organization (GO:0090224) | 3.16096410 |
| 67 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.15668557 |
| 68 | mitotic sister chromatid segregation (GO:0000070) | 3.15435862 |
| 69 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.12588768 |
| 70 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.12588768 |
| 71 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.11996656 |
| 72 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.11888444 |
| 73 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.11888444 |
| 74 | cullin deneddylation (GO:0010388) | 3.11538521 |
| 75 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.11439727 |
| 76 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.11439727 |
| 77 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.11439727 |
| 78 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.11348886 |
| 79 | ribosomal small subunit biogenesis (GO:0042274) | 3.10753797 |
| 80 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.10607927 |
| 81 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.10487872 |
| 82 | cell cycle G1/S phase transition (GO:0044843) | 3.10487872 |
| 83 | DNA replication-independent nucleosome organization (GO:0034724) | 3.09010856 |
| 84 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.09010856 |
| 85 | pseudouridine synthesis (GO:0001522) | 3.08973879 |
| 86 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.07439334 |
| 87 | protein localization to chromosome, centromeric region (GO:0071459) | 3.07438897 |
| 88 | viral transcription (GO:0019083) | 3.07277988 |
| 89 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.07144402 |
| 90 | membrane disassembly (GO:0030397) | 3.06647909 |
| 91 | nuclear envelope disassembly (GO:0051081) | 3.06647909 |
| 92 | protein K6-linked ubiquitination (GO:0085020) | 3.05864900 |
| 93 | mRNA splicing, via spliceosome (GO:0000398) | 3.02430684 |
| 94 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 3.02430684 |
| 95 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.02387614 |
| 96 | IMP metabolic process (GO:0046040) | 3.02195746 |
| 97 | RNA splicing, via transesterification reactions (GO:0000375) | 3.02007460 |
| 98 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.01608931 |
| 99 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.99721933 |
| 100 | positive regulation of viral transcription (GO:0050434) | 2.98685245 |
| 101 | translational initiation (GO:0006413) | 2.95998629 |
| 102 | histone exchange (GO:0043486) | 2.94936258 |
| 103 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.93420792 |
| 104 | viral mRNA export from host cell nucleus (GO:0046784) | 2.93015783 |
| 105 | kinetochore organization (GO:0051383) | 2.92620118 |
| 106 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.92332335 |
| 107 | ATP synthesis coupled proton transport (GO:0015986) | 2.92332335 |
| 108 | rRNA methylation (GO:0031167) | 2.91267657 |
| 109 | base-excision repair, AP site formation (GO:0006285) | 2.90977170 |
| 110 | positive regulation of chromosome segregation (GO:0051984) | 2.90054174 |
| 111 | cellular component biogenesis (GO:0044085) | 2.89950620 |
| 112 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.88958222 |
| 113 | positive regulation of ligase activity (GO:0051351) | 2.87711988 |
| 114 | DNA-templated transcription, elongation (GO:0006354) | 2.87562274 |
| 115 | regulation of chemokine biosynthetic process (GO:0045073) | 2.87029970 |
| 116 | regulation of mitochondrial translation (GO:0070129) | 2.85609126 |
| 117 | response to peptidoglycan (GO:0032494) | 2.85354374 |
| 118 | purine nucleotide salvage (GO:0032261) | 2.84700318 |
| 119 | protein targeting to mitochondrion (GO:0006626) | 2.82689745 |
| 120 | translational termination (GO:0006415) | 2.80493893 |
| 121 | neutrophil activation involved in immune response (GO:0002283) | 2.80198675 |
| 122 | defense response to protozoan (GO:0042832) | 2.78235798 |
| 123 | negative regulation of B cell apoptotic process (GO:0002903) | 2.72887084 |
| 124 | myeloid dendritic cell differentiation (GO:0043011) | 2.71454037 |
| 125 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.69187343 |
| 126 | establishment of protein localization to mitochondrion (GO:0072655) | 2.67266665 |
| 127 | myeloid dendritic cell activation (GO:0001773) | 2.66802146 |
| 128 | response to protozoan (GO:0001562) | 2.66485528 |
| 129 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.65356870 |
| 130 | negative regulation of cell killing (GO:0031342) | 2.64856894 |
| 131 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.64856894 |
| 132 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.64649625 |
| 133 | protein targeting to ER (GO:0045047) | 2.64136770 |
| 134 | negative regulation of interleukin-12 production (GO:0032695) | 2.64106070 |
| 135 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.62848471 |
| 136 | negative regulation of protein ubiquitination (GO:0031397) | 2.62838023 |
| 137 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.61978560 |
| 138 | modulation by symbiont of host immune response (GO:0052553) | 2.61978560 |
| 139 | positive regulation by symbiont of host defense response (GO:0052509) | 2.61978560 |
| 140 | modulation by symbiont of host defense response (GO:0052031) | 2.61978560 |
| 141 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.61978560 |
| 142 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.61978560 |
| 143 | translational elongation (GO:0006414) | 2.61950548 |
| 144 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.61689495 |
| 145 | viral life cycle (GO:0019058) | 2.61477557 |
| 146 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59658790 |
| 147 | cotranslational protein targeting to membrane (GO:0006613) | 2.58413354 |
| 148 | protein localization to mitochondrion (GO:0070585) | 2.58199154 |
| 149 | protein localization to endoplasmic reticulum (GO:0070972) | 2.56688668 |
| 150 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.55849655 |
| 151 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.55445291 |
| 152 | nucleotide salvage (GO:0043173) | 2.52950419 |
| 153 | leukocyte aggregation (GO:0070486) | 2.52018039 |
| 154 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.51864116 |
| 155 | positive regulation of cell cycle arrest (GO:0071158) | 2.51675765 |
| 156 | response to interferon-beta (GO:0035456) | 2.51631670 |
| 157 | regulation of ligase activity (GO:0051340) | 2.51497021 |
| 158 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.48597480 |
| 159 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.48092718 |
| 160 | positive regulation of isotype switching (GO:0045830) | 2.45747918 |
| 161 | GDP-mannose metabolic process (GO:0019673) | 2.45273385 |
| 162 | establishment of viral latency (GO:0019043) | 2.44422091 |
| 163 | regulation of immunoglobulin secretion (GO:0051023) | 2.44111187 |
| 164 | immunoglobulin mediated immune response (GO:0016064) | 2.43427428 |
| 165 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.42960838 |
| 166 | purine-containing compound salvage (GO:0043101) | 2.41755420 |
| 167 | translation (GO:0006412) | 2.41064410 |
| 168 | nucleoside salvage (GO:0043174) | 2.39986689 |
| 169 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.38591018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.24708382 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.16314473 |
| 3 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.64633694 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.59704514 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.45810456 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.38687369 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.35921249 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.32774819 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.32473297 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.31316299 |
| 11 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.30847015 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.14467143 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.13309543 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.07114060 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.91251564 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.88739535 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.84741770 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.75237820 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.61223616 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.58939774 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.38882230 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.36966148 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.33555174 |
| 24 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.29995662 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.26101990 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.20938369 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.14140312 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.11474978 |
| 29 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.06911611 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.05008397 |
| 31 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.03516368 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99438036 |
| 33 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.93505540 |
| 34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.91390132 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.90444571 |
| 36 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.88925007 |
| 37 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78980193 |
| 38 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.76981829 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.76872517 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.73093839 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72112316 |
| 42 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.68832214 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.68829044 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.67888448 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67326933 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.66085830 |
| 47 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.64778140 |
| 48 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.64022538 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.63813998 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63079584 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.59815397 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58113799 |
| 53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.55635436 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53882724 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53193283 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.52264319 |
| 57 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51856174 |
| 58 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.51500042 |
| 59 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.51356500 |
| 60 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44613034 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44473981 |
| 62 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41870263 |
| 63 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.41207892 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.40473860 |
| 65 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.40009998 |
| 66 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.39895888 |
| 67 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38215324 |
| 68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32581709 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32196756 |
| 70 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.28827823 |
| 71 | MYC_22102868_ChIP-Seq_BL_Human | 1.25270016 |
| 72 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.23924605 |
| 73 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23605331 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22615146 |
| 75 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20901601 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.20658938 |
| 77 | MAF_26560356_Chip-Seq_TH1_Human | 1.19677242 |
| 78 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19406770 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19145502 |
| 80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17544912 |
| 81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17518442 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16221386 |
| 83 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16192633 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 1.15696392 |
| 85 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13933583 |
| 86 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12722470 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11921049 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11651080 |
| 89 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11500929 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11087899 |
| 91 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10768547 |
| 92 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.09391530 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07974201 |
| 94 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07690147 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05241549 |
| 96 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.05122003 |
| 97 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05059009 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04375641 |
| 99 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03589545 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03309849 |
| 101 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03293294 |
| 102 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02704107 |
| 103 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02226649 |
| 104 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01526581 |
| 105 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01195001 |
| 106 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01167942 |
| 107 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.01068330 |
| 108 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.00829079 |
| 109 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00740355 |
| 110 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99638155 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99413869 |
| 112 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99327412 |
| 113 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.99039497 |
| 114 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.97740344 |
| 115 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97652681 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97344654 |
| 117 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93930588 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92554573 |
| 119 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90773549 |
| 120 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.90215359 |
| 121 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.89870116 |
| 122 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88939360 |
| 123 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.88816166 |
| 124 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88080174 |
| 125 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.85449231 |
| 126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85388030 |
| 127 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.84616786 |
| 128 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.83963545 |
| 129 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.82750722 |
| 130 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.81891607 |
| 131 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81144535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.42845333 |
| 2 | MP0003111_abnormal_nucleus_morphology | 4.36682207 |
| 3 | MP0010094_abnormal_chromosome_stability | 4.11639166 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 4.09961503 |
| 5 | MP0003077_abnormal_cell_cycle | 4.00124920 |
| 6 | MP0003436_decreased_susceptibility_to | 3.49958975 |
| 7 | MP0008058_abnormal_DNA_repair | 3.45842597 |
| 8 | MP0008007_abnormal_cellular_replicative | 3.42545467 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.24613390 |
| 10 | MP0001853_heart_inflammation | 3.17406595 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 3.00608228 |
| 12 | MP0009785_altered_susceptibility_to | 2.90207435 |
| 13 | MP0003724_increased_susceptibility_to | 2.76307154 |
| 14 | MP0008057_abnormal_DNA_replication | 2.72004984 |
| 15 | MP0008932_abnormal_embryonic_tissue | 2.67019294 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.62854216 |
| 17 | MP0003303_peritoneal_inflammation | 2.58185538 |
| 18 | MP0001730_embryonic_growth_arrest | 2.45445666 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.28810679 |
| 20 | MP0002419_abnormal_innate_immunity | 2.26034120 |
| 21 | MP0001800_abnormal_humoral_immune | 2.23984915 |
| 22 | MP0005025_abnormal_response_to | 2.21566939 |
| 23 | MP0000350_abnormal_cell_proliferation | 2.20584711 |
| 24 | MP0003123_paternal_imprinting | 2.19394775 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.17671637 |
| 26 | MP0002723_abnormal_immune_serum | 2.15418281 |
| 27 | MP0009278_abnormal_bone_marrow | 2.06248337 |
| 28 | MP0001790_abnormal_immune_system | 2.04998393 |
| 29 | MP0005387_immune_system_phenotype | 2.04998393 |
| 30 | MP0006082_CNS_inflammation | 2.04540987 |
| 31 | MP0009840_abnormal_foam_cell | 2.01074492 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.97457727 |
| 33 | MP0003786_premature_aging | 1.96251603 |
| 34 | MP0003718_maternal_effect | 1.93102515 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.91408922 |
| 36 | MP0000685_abnormal_immune_system | 1.90108621 |
| 37 | MP0002405_respiratory_system_inflammati | 1.88995662 |
| 38 | MP0005503_abnormal_tendon_morphology | 1.83022788 |
| 39 | MP0004947_skin_inflammation | 1.75268240 |
| 40 | MP0001873_stomach_inflammation | 1.71867035 |
| 41 | MP0010307_abnormal_tumor_latency | 1.71414861 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.71312429 |
| 43 | MP0009764_decreased_sensitivity_to | 1.71051899 |
| 44 | MP0008260_abnormal_autophagy | 1.70766979 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.69751374 |
| 46 | MP0001529_abnormal_vocalization | 1.68823016 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.61903567 |
| 48 | MP0001697_abnormal_embryo_size | 1.59675356 |
| 49 | MP0002653_abnormal_ependyma_morphology | 1.59069861 |
| 50 | MP0003950_abnormal_plasma_membrane | 1.54823336 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.52541891 |
| 52 | MP0006292_abnormal_olfactory_placode | 1.51404616 |
| 53 | MP0002080_prenatal_lethality | 1.47968859 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.47015631 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.47015631 |
| 56 | MP0000313_abnormal_cell_death | 1.46634975 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.44735263 |
| 58 | MP0002085_abnormal_embryonic_tissue | 1.42948413 |
| 59 | MP0002132_abnormal_respiratory_system | 1.42838236 |
| 60 | MP0000343_altered_response_to | 1.40104171 |
| 61 | MP0005380_embryogenesis_phenotype | 1.40020261 |
| 62 | MP0001672_abnormal_embryogenesis/_devel | 1.40020261 |
| 63 | MP0005310_abnormal_salivary_gland | 1.37418068 |
| 64 | MP0000358_abnormal_cell_content/ | 1.37146361 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.34144922 |
| 66 | MP0004133_heterotaxia | 1.33602001 |
| 67 | MP0008469_abnormal_protein_level | 1.32131185 |
| 68 | MP0004510_myositis | 1.30119511 |
| 69 | MP0001293_anophthalmia | 1.29652881 |
| 70 | MP0003121_genomic_imprinting | 1.22846867 |
| 71 | MP0002084_abnormal_developmental_patter | 1.22802738 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 1.22716967 |
| 73 | MP0003315_abnormal_perineum_morphology | 1.21531542 |
| 74 | MP0000490_abnormal_crypts_of | 1.20362113 |
| 75 | MP0002019_abnormal_tumor_incidence | 1.18646016 |
| 76 | MP0003984_embryonic_growth_retardation | 1.16200158 |
| 77 | MP0002088_abnormal_embryonic_growth/wei | 1.11817568 |
| 78 | MP0000537_abnormal_urethra_morphology | 1.10756898 |
| 79 | MP0001727_abnormal_embryo_implantation | 1.07632809 |
| 80 | MP0005384_cellular_phenotype | 1.07112712 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 1.07057500 |
| 82 | MP0008789_abnormal_olfactory_epithelium | 1.06132616 |
| 83 | MP0003075_altered_response_to | 1.04614810 |
| 84 | MP0003866_abnormal_defecation | 1.00222593 |
| 85 | MP0005166_decreased_susceptibility_to | 0.99148327 |
| 86 | MP0002210_abnormal_sex_determination | 0.99031983 |
| 87 | MP0008995_early_reproductive_senescence | 0.98887074 |
| 88 | MP0003172_abnormal_lysosome_physiology | 0.97252354 |
| 89 | MP0002398_abnormal_bone_marrow | 0.96961552 |
| 90 | MP0000703_abnormal_thymus_morphology | 0.96305406 |
| 91 | MP0003941_abnormal_skin_development | 0.95610996 |
| 92 | MP0005621_abnormal_cell_physiology | 0.95370398 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.95035673 |
| 94 | MP0002138_abnormal_hepatobiliary_system | 0.94748644 |
| 95 | MP0002751_abnormal_autonomic_nervous | 0.93894867 |
| 96 | MP0002722_abnormal_immune_system | 0.93449596 |
| 97 | MP0009672_abnormal_birth_weight | 0.93444721 |
| 98 | MP0002160_abnormal_reproductive_system | 0.91445916 |
| 99 | MP0006054_spinal_hemorrhage | 0.91076127 |
| 100 | MP0004197_abnormal_fetal_growth/weight/ | 0.90227380 |
| 101 | MP0002086_abnormal_extraembryonic_tissu | 0.90101526 |
| 102 | MP0003119_abnormal_digestive_system | 0.89831870 |
| 103 | MP0002089_abnormal_postnatal_growth/wei | 0.88644299 |
| 104 | MP0001145_abnormal_male_reproductive | 0.88107749 |
| 105 | MP0005464_abnormal_platelet_physiology | 0.88020610 |
| 106 | MP0003186_abnormal_redox_activity | 0.87761869 |
| 107 | MP0009763_increased_sensitivity_to | 0.87205946 |
| 108 | MP0002254_reproductive_system_inflammat | 0.86189930 |
| 109 | MP0001929_abnormal_gametogenesis | 0.86043501 |
| 110 | MP0008873_increased_physiological_sensi | 0.85094771 |
| 111 | MP0000689_abnormal_spleen_morphology | 0.84749448 |
| 112 | MP0005499_abnormal_olfactory_system | 0.84232921 |
| 113 | MP0005394_taste/olfaction_phenotype | 0.84232921 |
| 114 | MP0000428_abnormal_craniofacial_morphol | 0.83931628 |
| 115 | MP0003011_delayed_dark_adaptation | 0.83306280 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.81917131 |
| 117 | MP0003890_abnormal_embryonic-extraembry | 0.81619017 |
| 118 | MP0002429_abnormal_blood_cell | 0.81414973 |
| 119 | MP0001849_ear_inflammation | 0.78807735 |
| 120 | MP0005389_reproductive_system_phenotype | 0.78748864 |
| 121 | MP0003861_abnormal_nervous_system | 0.78714761 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.78607127 |
| 123 | MP0003937_abnormal_limbs/digits/tail_de | 0.78051038 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.77763678 |
| 125 | MP0001286_abnormal_eye_development | 0.75026040 |
| 126 | MP0005390_skeleton_phenotype | 0.74329027 |
| 127 | MP0002111_abnormal_tail_morphology | 0.73965277 |
| 128 | MP0004808_abnormal_hematopoietic_stem | 0.72347759 |
| 129 | MP0000858_altered_metastatic_potential | 0.71945795 |
| 130 | MP0010030_abnormal_orbit_morphology | 0.71600096 |
| 131 | MP0005023_abnormal_wound_healing | 0.71171853 |
| 132 | MP0003938_abnormal_ear_development | 0.70895886 |
| 133 | MP0002092_abnormal_eye_morphology | 0.70100753 |
| 134 | MP0010352_gastrointestinal_tract_polyps | 0.69840852 |
| 135 | MP0001216_abnormal_epidermal_layer | 0.69640922 |
| 136 | MP0000716_abnormal_immune_system | 0.69508662 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.69270176 |
| 138 | MP0001905_abnormal_dopamine_level | 0.69193695 |
| 139 | MP0003806_abnormal_nucleotide_metabolis | 0.68963944 |
| 140 | MP0005075_abnormal_melanosome_morpholog | 0.68910820 |
| 141 | MP0001542_abnormal_bone_strength | 0.66820527 |
| 142 | MP0002998_abnormal_bone_remodeling | 0.66751497 |
| 143 | MP0000653_abnormal_sex_gland | 0.66443454 |
| 144 | MP0000733_abnormal_muscle_development | 0.66415789 |
| 145 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64261354 |
| 146 | MP0008438_abnormal_cutaneous_collagen | 0.64109067 |
| 147 | MP0005501_abnormal_skin_physiology | 0.60743359 |
| 148 | MP0005508_abnormal_skeleton_morphology | 0.60098373 |
| 149 | MP0005391_vision/eye_phenotype | 0.60073774 |
| 150 | MP0006035_abnormal_mitochondrial_morpho | 0.59994297 |
| 151 | MP0003566_abnormal_cell_adhesion | 0.59920019 |
| 152 | MP0001119_abnormal_female_reproductive | 0.57876782 |
| 153 | MP0002114_abnormal_axial_skeleton | 0.57259143 |
| 154 | MP0005408_hypopigmentation | 0.56638379 |
| 155 | MP0005671_abnormal_response_to | 0.56021655 |
| 156 | MP0000015_abnormal_ear_pigmentation | 0.55659451 |
| 157 | MP0003448_altered_tumor_morphology | 0.55331076 |
| 158 | MP0002420_abnormal_adaptive_immunity | 0.54563574 |
| 159 | MP0001819_abnormal_immune_cell | 0.54293114 |
| 160 | MP0002233_abnormal_nose_morphology | 0.52316870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral hypomyelination (HP:0006808) | 6.08340823 |
| 2 | Birth length less than 3rd percentile (HP:0003561) | 5.52684616 |
| 3 | Breast hypoplasia (HP:0003187) | 4.10147449 |
| 4 | CNS hypomyelination (HP:0003429) | 3.90682404 |
| 5 | Stomatitis (HP:0010280) | 3.89385784 |
| 6 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.78011824 |
| 7 | Oral leukoplakia (HP:0002745) | 3.70310433 |
| 8 | Abnormality of the labia minora (HP:0012880) | 3.65406494 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.62983919 |
| 10 | Patellar aplasia (HP:0006443) | 3.60525111 |
| 11 | Abnormal number of incisors (HP:0011064) | 3.49471684 |
| 12 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.44804259 |
| 13 | Rough bone trabeculation (HP:0100670) | 3.40721336 |
| 14 | Microvesicular hepatic steatosis (HP:0001414) | 3.37836471 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.36619127 |
| 16 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.36619127 |
| 17 | Carpal bone hypoplasia (HP:0001498) | 3.33018706 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.32046263 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.31801939 |
| 20 | Hepatocellular necrosis (HP:0001404) | 3.31432222 |
| 21 | Mitochondrial inheritance (HP:0001427) | 3.26130144 |
| 22 | Reticulocytopenia (HP:0001896) | 3.23721858 |
| 23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.20555281 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 3.20307661 |
| 25 | Degeneration of anterior horn cells (HP:0002398) | 3.15490373 |
| 26 | Abnormality of the anterior horn cell (HP:0006802) | 3.15490373 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.04851071 |
| 28 | Premature graying of hair (HP:0002216) | 2.98425485 |
| 29 | Aplastic anemia (HP:0001915) | 2.96830780 |
| 30 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.93934905 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 2.89382827 |
| 32 | Loss of speech (HP:0002371) | 2.87552269 |
| 33 | Chromsome breakage (HP:0040012) | 2.87417939 |
| 34 | Myositis (HP:0100614) | 2.87304380 |
| 35 | Increased CSF lactate (HP:0002490) | 2.85567732 |
| 36 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.81287644 |
| 37 | Renal Fanconi syndrome (HP:0001994) | 2.78364695 |
| 38 | Increased intramyocellular lipid droplets (HP:0012240) | 2.78325335 |
| 39 | 3-Methylglutaconic aciduria (HP:0003535) | 2.77851333 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.77823772 |
| 41 | Hepatosplenomegaly (HP:0001433) | 2.76542029 |
| 42 | Increased IgM level (HP:0003496) | 2.70310295 |
| 43 | Acute necrotizing encephalopathy (HP:0006965) | 2.69721845 |
| 44 | Tongue fasciculations (HP:0001308) | 2.67882568 |
| 45 | Abnormal trabecular bone morphology (HP:0100671) | 2.66567432 |
| 46 | Facial cleft (HP:0002006) | 2.65178095 |
| 47 | Selective tooth agenesis (HP:0001592) | 2.64883516 |
| 48 | Absent radius (HP:0003974) | 2.63307795 |
| 49 | Hepatic necrosis (HP:0002605) | 2.62909633 |
| 50 | Respiratory difficulties (HP:0002880) | 2.62873562 |
| 51 | Recurrent viral infections (HP:0004429) | 2.62512395 |
| 52 | Impulsivity (HP:0100710) | 2.62119450 |
| 53 | Increased muscle lipid content (HP:0009058) | 2.60407869 |
| 54 | Postnatal microcephaly (HP:0005484) | 2.57342268 |
| 55 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.54983658 |
| 56 | Eczematoid dermatitis (HP:0000976) | 2.54844720 |
| 57 | Exertional dyspnea (HP:0002875) | 2.54304360 |
| 58 | Colon cancer (HP:0003003) | 2.49043063 |
| 59 | Obstructive lung disease (HP:0006536) | 2.48598151 |
| 60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48598151 |
| 61 | IgG deficiency (HP:0004315) | 2.48426509 |
| 62 | Absent forearm bone (HP:0003953) | 2.46931106 |
| 63 | Aplasia involving forearm bones (HP:0009822) | 2.46931106 |
| 64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.45010932 |
| 65 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.45010932 |
| 66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.45010932 |
| 67 | Bone marrow hypocellularity (HP:0005528) | 2.44577353 |
| 68 | Agnosia (HP:0010524) | 2.44462261 |
| 69 | IgM deficiency (HP:0002850) | 2.41235016 |
| 70 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.40392693 |
| 71 | Type I transferrin isoform profile (HP:0003642) | 2.39168943 |
| 72 | Orchitis (HP:0100796) | 2.39143306 |
| 73 | Ileus (HP:0002595) | 2.38346185 |
| 74 | Horseshoe kidney (HP:0000085) | 2.37847463 |
| 75 | Meckel diverticulum (HP:0002245) | 2.37592699 |
| 76 | Microretrognathia (HP:0000308) | 2.37379873 |
| 77 | Increased serum ferritin (HP:0003281) | 2.36906194 |
| 78 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.36079374 |
| 79 | Abnormality of the alveolar ridges (HP:0006477) | 2.35492433 |
| 80 | Absent epiphyses (HP:0010577) | 2.35299841 |
| 81 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.35299841 |
| 82 | Trismus (HP:0000211) | 2.33513349 |
| 83 | Abnormality of the preputium (HP:0100587) | 2.33412664 |
| 84 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.31753615 |
| 85 | Progressive external ophthalmoplegia (HP:0000590) | 2.30708716 |
| 86 | Increased serum lactate (HP:0002151) | 2.30167192 |
| 87 | Delusions (HP:0000746) | 2.28909588 |
| 88 | Acute encephalopathy (HP:0006846) | 2.28374529 |
| 89 | Optic neuritis (HP:0100653) | 2.27411506 |
| 90 | Retrobulbar optic neuritis (HP:0100654) | 2.27411506 |
| 91 | Hypoplastic pelvis (HP:0008839) | 2.25324533 |
| 92 | Abnormality of the umbilical cord (HP:0010881) | 2.25036456 |
| 93 | Personality changes (HP:0000751) | 2.24991318 |
| 94 | Abnormality of the ileum (HP:0001549) | 2.24863888 |
| 95 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.24040603 |
| 96 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.24040603 |
| 97 | Single umbilical artery (HP:0001195) | 2.24040603 |
| 98 | Natal tooth (HP:0000695) | 2.22180618 |
| 99 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.19307540 |
| 100 | Pancytopenia (HP:0001876) | 2.19216084 |
| 101 | Muscle fibrillation (HP:0010546) | 2.19198828 |
| 102 | Thrombocytosis (HP:0001894) | 2.18790188 |
| 103 | Abnormal number of erythroid precursors (HP:0012131) | 2.17491242 |
| 104 | Vacuolated lymphocytes (HP:0001922) | 2.17407150 |
| 105 | Mild short stature (HP:0003502) | 2.16976675 |
| 106 | Recurrent fungal infections (HP:0002841) | 2.16655646 |
| 107 | Systemic lupus erythematosus (HP:0002725) | 2.14681570 |
| 108 | Progressive macrocephaly (HP:0004481) | 2.12790841 |
| 109 | Premature ovarian failure (HP:0008209) | 2.12508868 |
| 110 | Unsteady gait (HP:0002317) | 2.12268067 |
| 111 | Secondary amenorrhea (HP:0000869) | 2.11744903 |
| 112 | Abnormality of chromosome stability (HP:0003220) | 2.11677963 |
| 113 | Premature loss of primary teeth (HP:0006323) | 2.11117196 |
| 114 | Lactic acidosis (HP:0003128) | 2.10663349 |
| 115 | Pallor (HP:0000980) | 2.08400847 |
| 116 | Poor head control (HP:0002421) | 2.08367230 |
| 117 | Increased serum pyruvate (HP:0003542) | 2.07221189 |
| 118 | Abnormality of glycolysis (HP:0004366) | 2.07221189 |
| 119 | Glossoptosis (HP:0000162) | 2.06137071 |
| 120 | Ragged-red muscle fibers (HP:0003200) | 2.03817359 |
| 121 | Small intestinal stenosis (HP:0012848) | 2.03392491 |
| 122 | Duodenal stenosis (HP:0100867) | 2.03392491 |
| 123 | Lymphoma (HP:0002665) | 2.02543967 |
| 124 | Abnormality of alanine metabolism (HP:0010916) | 2.02175556 |
| 125 | Hyperalaninemia (HP:0003348) | 2.02175556 |
| 126 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.02175556 |
| 127 | Sloping forehead (HP:0000340) | 2.01151616 |
| 128 | Abnormality of renal resorption (HP:0011038) | 2.00244922 |
| 129 | Panhypogammaglobulinemia (HP:0003139) | 2.00170324 |
| 130 | Exercise intolerance (HP:0003546) | 1.97524479 |
| 131 | Parakeratosis (HP:0001036) | 1.97332852 |
| 132 | Recurrent skin infections (HP:0001581) | 1.97024670 |
| 133 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.96569823 |
| 134 | Abnormal lung lobation (HP:0002101) | 1.96492037 |
| 135 | Respiratory failure (HP:0002878) | 1.95836461 |
| 136 | Congenital, generalized hypertrichosis (HP:0004540) | 1.95420342 |
| 137 | Ependymoma (HP:0002888) | 1.95279284 |
| 138 | Macrocytic anemia (HP:0001972) | 1.93354919 |
| 139 | Neoplasm of the pancreas (HP:0002894) | 1.92988419 |
| 140 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92164518 |
| 141 | Autoimmune thrombocytopenia (HP:0001973) | 1.90200983 |
| 142 | Neutropenia (HP:0001875) | 1.89719006 |
| 143 | Interstitial pulmonary disease (HP:0006530) | 1.89652517 |
| 144 | Optic nerve coloboma (HP:0000588) | 1.89445506 |
| 145 | Duplicated collecting system (HP:0000081) | 1.88049210 |
| 146 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.87481125 |
| 147 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87481125 |
| 148 | Abnormal protein glycosylation (HP:0012346) | 1.87481125 |
| 149 | Abnormal glycosylation (HP:0012345) | 1.87481125 |
| 150 | Increased cerebral lipofuscin (HP:0011813) | 1.87052962 |
| 151 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.86908276 |
| 152 | Hypertensive crisis (HP:0100735) | 1.86568061 |
| 153 | Meningitis (HP:0001287) | 1.86190928 |
| 154 | T lymphocytopenia (HP:0005403) | 1.85318212 |
| 155 | Slender long bone (HP:0003100) | 1.85289626 |
| 156 | Diaphragmatic weakness (HP:0009113) | 1.85234268 |
| 157 | Granulocytopenia (HP:0001913) | 1.84910165 |
| 158 | Cellulitis (HP:0100658) | 1.84866328 |
| 159 | Tracheoesophageal fistula (HP:0002575) | 1.83882478 |
| 160 | Triphalangeal thumb (HP:0001199) | 1.83784892 |
| 161 | Neonatal short-limb short stature (HP:0008921) | 1.83434513 |
| 162 | Multiple enchondromatosis (HP:0005701) | 1.82619943 |
| 163 | Abnormality of T cells (HP:0002843) | 1.82602690 |
| 164 | Abnormality of iron homeostasis (HP:0011031) | 1.81959427 |
| 165 | Cortical visual impairment (HP:0100704) | 1.81910250 |
| 166 | Absent thumb (HP:0009777) | 1.81450801 |
| 167 | Cellular immunodeficiency (HP:0005374) | 1.81419844 |
| 168 | Pulmonary fibrosis (HP:0002206) | 1.80954564 |
| 169 | Supernumerary spleens (HP:0009799) | 1.80536930 |
| 170 | IgA deficiency (HP:0002720) | 1.80191894 |
| 171 | Emotional lability (HP:0000712) | 1.79551849 |
| 172 | Encephalitis (HP:0002383) | 1.79439885 |
| 173 | Asplenia (HP:0001746) | 1.78314931 |
| 174 | Irregular epiphyses (HP:0010582) | 1.78062008 |
| 175 | Abnormal gallbladder physiology (HP:0012438) | 1.74356352 |
| 176 | Cholecystitis (HP:0001082) | 1.74356352 |
| 177 | B lymphocytopenia (HP:0010976) | 1.74329675 |
| 178 | Progressive muscle weakness (HP:0003323) | 1.74290314 |
| 179 | Myelodysplasia (HP:0002863) | 1.74039929 |
| 180 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.73654691 |
| 181 | Conical tooth (HP:0000698) | 1.73389770 |
| 182 | Abnormality of the clitoris (HP:0000056) | 1.73357220 |
| 183 | Abnormality of the renal collecting system (HP:0004742) | 1.73094794 |
| 184 | Ureteral duplication (HP:0000073) | 1.72395021 |
| 185 | Death in infancy (HP:0001522) | 1.71803380 |
| 186 | Medulloblastoma (HP:0002885) | 1.71309532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.27226037 |
| 2 | EIF2AK1 | 4.48576225 |
| 3 | WEE1 | 3.06350881 |
| 4 | VRK2 | 2.93392434 |
| 5 | TLK1 | 2.85253110 |
| 6 | TSSK6 | 2.76624363 |
| 7 | CDC7 | 2.50931950 |
| 8 | SRPK1 | 2.47554629 |
| 9 | CCNB1 | 2.30347218 |
| 10 | IRAK3 | 2.24965987 |
| 11 | TESK2 | 2.11931215 |
| 12 | EIF2AK3 | 2.08285121 |
| 13 | ACVR1B | 2.07624273 |
| 14 | STK16 | 2.01754247 |
| 15 | VRK1 | 1.98946228 |
| 16 | PDK2 | 1.95385710 |
| 17 | TBK1 | 1.91450369 |
| 18 | MKNK1 | 1.89668837 |
| 19 | PLK1 | 1.76842296 |
| 20 | PLK3 | 1.76484631 |
| 21 | PLK4 | 1.74900406 |
| 22 | TXK | 1.73001896 |
| 23 | BRSK1 | 1.69404981 |
| 24 | INSRR | 1.68017543 |
| 25 | SIK3 | 1.67956581 |
| 26 | MAP3K11 | 1.67739312 |
| 27 | NEK2 | 1.67708870 |
| 28 | BRSK2 | 1.67146037 |
| 29 | TTK | 1.62899938 |
| 30 | NEK1 | 1.56028193 |
| 31 | DYRK2 | 1.51662647 |
| 32 | GRK6 | 1.51424481 |
| 33 | MATK | 1.47825392 |
| 34 | ARAF | 1.47374481 |
| 35 | TYK2 | 1.45849375 |
| 36 | MAP3K14 | 1.44985862 |
| 37 | BCKDK | 1.43604745 |
| 38 | PRPF4B | 1.42646531 |
| 39 | BCR | 1.41042657 |
| 40 | LIMK1 | 1.36600088 |
| 41 | AURKA | 1.33678190 |
| 42 | KDR | 1.33665027 |
| 43 | IKBKE | 1.32665498 |
| 44 | EPHA2 | 1.31328508 |
| 45 | PIM2 | 1.30111670 |
| 46 | AURKB | 1.28938788 |
| 47 | ZAK | 1.28811493 |
| 48 | DYRK3 | 1.25973867 |
| 49 | ATR | 1.24646247 |
| 50 | TRIB3 | 1.24162562 |
| 51 | PBK | 1.22889987 |
| 52 | CDK7 | 1.22306614 |
| 53 | CHEK2 | 1.21994055 |
| 54 | MAP3K3 | 1.21085349 |
| 55 | NME1 | 1.20545071 |
| 56 | TESK1 | 1.19838807 |
| 57 | CDK19 | 1.18585028 |
| 58 | BRAF | 1.17670876 |
| 59 | PASK | 1.16758110 |
| 60 | ERN1 | 1.11400378 |
| 61 | MAP2K3 | 1.08336242 |
| 62 | MET | 1.07695078 |
| 63 | BLK | 1.07423640 |
| 64 | RPS6KA4 | 1.07231818 |
| 65 | TRPM7 | 1.05774241 |
| 66 | NME2 | 1.05488088 |
| 67 | GRK7 | 1.04145558 |
| 68 | TAOK1 | 1.03688259 |
| 69 | MKNK2 | 1.02123501 |
| 70 | MAP3K8 | 1.01870047 |
| 71 | CLK1 | 1.01122532 |
| 72 | IRAK4 | 1.00656484 |
| 73 | ABL2 | 1.00433076 |
| 74 | PAK4 | 0.96488302 |
| 75 | PAK1 | 0.95161623 |
| 76 | MST4 | 0.93338536 |
| 77 | CHEK1 | 0.92649493 |
| 78 | LRRK2 | 0.92347682 |
| 79 | MAP2K2 | 0.91712359 |
| 80 | TAOK3 | 0.91536570 |
| 81 | TGFBR1 | 0.89708345 |
| 82 | CHUK | 0.87468936 |
| 83 | EIF2AK2 | 0.87461177 |
| 84 | STK38L | 0.86893883 |
| 85 | SIK1 | 0.85092678 |
| 86 | FES | 0.83046353 |
| 87 | CSK | 0.81866463 |
| 88 | FGR | 0.81145260 |
| 89 | STK4 | 0.75768650 |
| 90 | RPS6KA5 | 0.75421529 |
| 91 | NEK6 | 0.75206948 |
| 92 | AKT3 | 0.74161742 |
| 93 | CDK8 | 0.73001687 |
| 94 | MARK3 | 0.72617859 |
| 95 | LYN | 0.72303815 |
| 96 | CDK2 | 0.70709148 |
| 97 | ALK | 0.70162626 |
| 98 | MELK | 0.69190359 |
| 99 | ZAP70 | 0.68317233 |
| 100 | TNK2 | 0.67751716 |
| 101 | PIM1 | 0.67470942 |
| 102 | STK10 | 0.66165617 |
| 103 | SMG1 | 0.64523046 |
| 104 | CDK18 | 0.62488420 |
| 105 | SCYL2 | 0.61751593 |
| 106 | CDK11A | 0.60067149 |
| 107 | CDK1 | 0.59642065 |
| 108 | CDK15 | 0.58156258 |
| 109 | DAPK3 | 0.57104805 |
| 110 | SIK2 | 0.56834124 |
| 111 | PRKCI | 0.56718165 |
| 112 | NEK9 | 0.55430541 |
| 113 | RPS6KB2 | 0.52796123 |
| 114 | MAP4K1 | 0.52500790 |
| 115 | CSNK1G3 | 0.52457689 |
| 116 | CDK14 | 0.51448615 |
| 117 | LATS2 | 0.50686285 |
| 118 | MAP3K12 | 0.50645437 |
| 119 | CSNK2A1 | 0.48854776 |
| 120 | CDK4 | 0.47976265 |
| 121 | ATM | 0.46765636 |
| 122 | CSNK2A2 | 0.45903225 |
| 123 | BTK | 0.45507533 |
| 124 | MAPKAPK2 | 0.44271825 |
| 125 | MAP3K13 | 0.43809739 |
| 126 | DAPK1 | 0.43695236 |
| 127 | TGFBR2 | 0.43651435 |
| 128 | RPS6KA1 | 0.43599690 |
| 129 | LCK | 0.42126735 |
| 130 | BRD4 | 0.42078812 |
| 131 | STK24 | 0.41806889 |
| 132 | JAK3 | 0.39666312 |
| 133 | MAP2K6 | 0.38455815 |
| 134 | HCK | 0.37813136 |
| 135 | MOS | 0.37759991 |
| 136 | CDK12 | 0.37028572 |
| 137 | BMX | 0.35944363 |
| 138 | CDC42BPA | 0.35748850 |
| 139 | ILK | 0.34064058 |
| 140 | CSF1R | 0.33759010 |
| 141 | MAP3K5 | 0.33114408 |
| 142 | SYK | 0.32995020 |
| 143 | RPS6KL1 | 0.31821344 |
| 144 | RPS6KC1 | 0.31821344 |
| 145 | PLK2 | 0.29292832 |
| 146 | OXSR1 | 0.29054699 |
| 147 | IKBKB | 0.28748926 |
| 148 | ROCK2 | 0.28722739 |
| 149 | TAOK2 | 0.26995778 |
| 150 | CSNK1G1 | 0.26383227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.09577864 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.09572706 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.84195898 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.82580755 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.42767024 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 3.41349033 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 3.22160309 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 3.18167665 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.99192509 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.67595768 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.51432368 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 2.50019950 |
| 13 | Basal transcription factors_Homo sapiens_hsa03022 | 2.48321765 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.38151993 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.07524316 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.04554705 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.91604680 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.84896519 |
| 19 | RNA degradation_Homo sapiens_hsa03018 | 1.76616768 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74102588 |
| 21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.69491879 |
| 22 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.61397166 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.59750436 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.56945615 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.56245137 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54783938 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.49021307 |
| 28 | Purine metabolism_Homo sapiens_hsa00230 | 1.41748339 |
| 29 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.34757234 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33889501 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33283583 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.27132693 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26365680 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.24748141 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.23327605 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.20884626 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19533073 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14369365 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.11195952 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.10446411 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09631234 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.06762427 |
| 43 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06579701 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05771596 |
| 45 | Protein export_Homo sapiens_hsa03060 | 1.02229632 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95899133 |
| 47 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.95519068 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95324177 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 0.93695526 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93605218 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.92935338 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.91000573 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90372198 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88766815 |
| 55 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.85428937 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.84635368 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82460054 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80439686 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80147356 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78528152 |
| 61 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75696366 |
| 62 | Alcoholism_Homo sapiens_hsa05034 | 0.75311858 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74998408 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74004451 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72878521 |
| 66 | Bladder cancer_Homo sapiens_hsa05219 | 0.72850634 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72217649 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72132253 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71675659 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67715440 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67417287 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.64476718 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64332114 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63598964 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63164711 |
| 76 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.63071419 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61818495 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61359062 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.60769451 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59516843 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58517150 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56346025 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55287667 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.55247796 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54702918 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.53583738 |
| 87 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52095984 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50838134 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50765113 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49862385 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49615776 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48640300 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46740631 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46032360 |
| 95 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44228751 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43662578 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42460968 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.41832497 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38532152 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38262579 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36744474 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34784135 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32595907 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30253772 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29012097 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27700960 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26969256 |
| 108 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25825788 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25542324 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25443828 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.24921487 |
| 112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.24129261 |
| 113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23269569 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.23096295 |
| 115 | Hepatitis B_Homo sapiens_hsa05161 | 0.22770540 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22601368 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.21678169 |
| 118 | Allograft rejection_Homo sapiens_hsa05330 | 0.21607485 |
| 119 | Measles_Homo sapiens_hsa05162 | 0.21543947 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21026572 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.20577210 |
| 122 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20279604 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19517536 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.19246709 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.18555626 |
| 126 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17649517 |
| 127 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.17589076 |
| 128 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.17403921 |
| 129 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.16835294 |
| 130 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16586355 |
| 131 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.16534236 |
| 132 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.16316597 |
| 133 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14340532 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13881245 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.13564319 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13323096 |
| 137 | Galactose metabolism_Homo sapiens_hsa00052 | 0.12948424 |
| 138 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.12947417 |

